Cellebrite DI (CLBT) Stock Statistics & Valuation Metrics

Cellebrite DI has a market cap or net worth of $4.82B. The enterprise value is $5.01B.

Cellebrite DI has 239,470,060 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cellebrite DI’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Cellebrite DI is ―. Cellebrite DI’s PEG ratio is ―.

In the last 12 months, Cellebrite DI had revenue of 401.20M and earned -283.01M in profits. Earnings per share was -1.35.

In the last 12 months, operating cash flow was 126.84M and capital expenditures -9.47M, giving a free cash flow of 117.37M billion.

Cellebrite DI pays an annual dividend of ―, resulting in a dividend yield of ―

Cellebrite DI upcoming earnings date is May 14, 2025, TBA Not Confirmed.

Cellebrite DI as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Cellebrite DI has paid 7.02M in taxes.

Cellebrite DI EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Cellebrite DI has $447.22M in cash and marketable securities with $10.97M in debt, giving a net cash position of -$436.25M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Cellebrite DI is $27.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy